Profile
Leslie J.
Holsinger worked as a Group Leader at Sugen, Inc. and as the Head of Cell Biology Division at Celera Group.
Later, she worked as the Vice President of Biology at Virobay, Inc. from 2011 to 2016.
Currently, she is the Executive Vice President of Research and Development at Quince Therapeutics, Inc. since 2020.
Holsinger holds a doctorate from Northwestern University and an undergraduate degree from Occidental College.
Former positions of Leslie Holsinger
| Companies | Position | End |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-07-30 |
Virobay, Inc.
Virobay, Inc. Pharmaceuticals: MajorHealth Technology Develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases | Corporate Officer/Principal | 2015-12-31 |
Celera Group
Celera Group Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for cancer, autoimmune and inflammatory diseases | Corporate Officer/Principal | - |
Sugen, Inc.
Sugen, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs and related pharmaceutical products | Corporate Officer/Principal | - |
Training of Leslie Holsinger
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Sugen, Inc.
Sugen, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs and related pharmaceutical products | Health Technology |
Virobay, Inc.
Virobay, Inc. Pharmaceuticals: MajorHealth Technology Develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases | Health Technology |
Celera Group
Celera Group Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for cancer, autoimmune and inflammatory diseases | Health Technology |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Occidental College
Occidental College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quince Therapeutics, Inc.
Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
- Stock Market
- Insiders
- Leslie Holsinger
















